Transcranial Stimulation in Motor Stroke Rehabilitation
NCT ID: NCT02525393
Last Updated: 2015-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2012-03-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Physiatric evaluations (ARAT scale), neuropsychological assessment and ERP (P300) were performed before (1 week) and after (1 week) the end of each treatment. Furthermore, all patients underwent follow-up neuropsychological assessment 6 months after the end of each stimulation period and follow-up physiatric evaluation at 3 and 6 months after the end of each stimulation period.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of rTMS and tDCS on Motor Function in Stroke
NCT01574989
Effects of Brain Network by Simultaneous Dual-mode Stimulation in Subacute Stroke Patients
NCT03279640
TDCS-RTMS Intervention for Motor Function
NCT07257601
tDCS and rTMS in Patients With Early Disorders of Consciousness
NCT05820178
Transcranial Brain Stimulation in Vegetative State Patients
NCT01820923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
tDCS+rTMS
Stroke patients were treated with an initial two weeks of transcranial direct current stimulation and after six months with two weeks of repetitive transcranial magnetic stimulation.
tDCS
Stroke rehabilitation performed with the aid of a transcranial electrical stimulation device.
rTMS
Stroke rehabilitation performed with the aid of a repetitive transcranial magnetic stimulation device.
rTMS+tDCS
Stroke patients were treated with an initial two weeks of repetitive transcranial magnetic stimulation and after six months with two weeks of transcranial direct current stimulation.
tDCS
Stroke rehabilitation performed with the aid of a transcranial electrical stimulation device.
rTMS
Stroke rehabilitation performed with the aid of a repetitive transcranial magnetic stimulation device.
Sham stimulation
Stroke patients were treated with two weeks of sham transcranial direct current stimulation.
Sham
Stroke sham stimulation performed with the aid of a transcranial electrical stimulation device.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tDCS
Stroke rehabilitation performed with the aid of a transcranial electrical stimulation device.
rTMS
Stroke rehabilitation performed with the aid of a repetitive transcranial magnetic stimulation device.
Sham
Stroke sham stimulation performed with the aid of a transcranial electrical stimulation device.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* psychiatric disorders,
* degenerative neurological disorders,
* epilepsy,
* severe medical conditions,
* having been implanted a drug infusion system, spinal/brain-stimulator, or endovascular coil
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Turin, Italy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Federico Dagata
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Federico D'Agata, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Turin, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AOU Città della Salute e della Scienza
Turin, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEI 339
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.